Close Menu

NEW YORK (GenomeWeb) – BioMérieux today reported that its second quarter revenues rose approximately 3 percent year over year. The firm attributed growth to a diversified geographic footprint and comprehensive offerings.

For the three months ended June 30, BioMérieux reported revenues of €582.2 million ($677.1 million), up from €566.4 million in the prior-year period. Organic growth, at constant exchange rates and scope of consolidation, was about 8 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.